SLIDE 1 ICH Management
Andrew M. Demchuk MD FRCPC Director, Calgary Stroke Program Pillar 2 Chair APSS (Acute Care and Emergency Services) Heart and Stroke Foundation Chair in Stroke Research Professor University of Calgary
SLIDE 2
Epidemiology of ICH
Comprises 15% 10% of stroke in the NA/Europe 30% in the developing world 6 month prognosis 40% dead 40% disabled and dependent 20% independent
SLIDE 3 Mechanism - ICH
Hypertension
Treat the hypertension – may NOT be
necessary acutely
Drugs (eg. PPA, cocaine)
Lifestyle changes
Amyloid angiopathy
No treatment
AVM
Surgery, radiosurgery, embolization
SLIDE 4 Investigation of ICH for underlying etiology
Noncontrast CT +/- CT-angiography MRI with GRE/SWI Conventional angiography
Hypertension Amyloid angiopathy Arteriovenous malformation Intracranial aneurysm Cavernous angioma Dural venous sinus thrombosis Intracranial neoplasm Coagulopathy Cocaine or alcohol use
SLIDE 5 Severe Amyloid Angiopathy Pattern
Gradient echo imaging
SLIDE 6 Hypertensive Arteriolosclerosis Pattern
Gradient echo imaging
SLIDE 7 Acute CT for prognosis: ICH Volume Measurement, IVH, location
A x B x C / 2 A – greatest width B – greatest length C – depth
SLIDE 8 Prognosis
- Size and location of hematoma
- Presence of IVH
- Clinical deficit
SLIDE 9 2.5 hours after symptom onset
6.5 hours after onset, with enlargement of the hematoma due to ongoing bleeding
“Early Hematoma Growth”
SLIDE 10
SLIDE 11
Dripping with each passing minute
SLIDE 12 Case 1
- 48 year old hypertensive
- Onset 2 hours ago
- Right hemiplegia
- Basal ganglia ICH 20 ml
- Systolic BP 210
SLIDE 13
SLIDE 14 <150 systolic BP lowering marginal in ICH
SLIDE 15
SLIDE 16 More aggressive BP lowering in ICH no effect
SLIDE 17
SLIDE 18 ICH Management
Comprehensive stroke centre if severe deficits? BP <140 mmHg systolic but not much lower best
SLIDE 19 Case 2
- 78 year old afib on warfarin
- Subcortical ICH 6 ml
- Systolic BP 140
SLIDE 20
Anticoagulation major risk for hematoma expansion
SLIDE 21
Prothrombin Complex Concentrate for Coagulopathy
Clotting factors: FII, VII, IX and X, protein C and S.
SLIDE 22
SLIDE 23
Prothrombin Complex Concentrate for Coagulopathy
1000U INR 1.5-3 2000U if INR 3-5 3000U if INR >5
SLIDE 24
Praxbind bolus for Dabigatran associated ICH
SLIDE 25 ICH Management
Urine toxicology screen
CT/CTA should be standard INR STAT crucial
SLIDE 26
Our Imaging in ICH Philosophy:
Good Quality Plain CT and mCTA brain to view for abnormal arteries/veins and view the leakpoint! Don’t Leave the ED Without It!
SLIDE 27
SLIDE 28
Spot Sign Contrast Extravasation
SLIDE 29
rFVIIa ICH Trials Failed
SLIDE 30
Logarithmic curve of bleeding with increasing hemostasis then contraction
time ICH volume
SLIDE 31
Logarithmic curve of bleeding with increasing hemostasis then contraction
time ICH volume
SLIDE 32 Future Directions
- Hemostasis needs to be initiated much earlier
- Spot sign predicts HE but needs refinement
- Hemostatic ICH trial design should focus on:
- ultraearly time windows (<2h)
- Deferral or waiver of consent
- pre-hospital setting (CT ambulance)
SLIDE 33
Emerging acute tx of ICH
Hematoma expansion prevention therapy Surgical evacuation of ICH Thrombolysis in IVH
SLIDE 34 ICH Surgical Decision Making?
D E
SLIDE 35
When to Operate?
SLIDE 36 Hanley D et al. ISC 2012
SLIDE 37
SLIDE 38
SLIDE 39
Intraventricular Hemorrhage
SLIDE 40
tPA instillation 1 mg q8h dual vent drains
CLEAR IVH Phase 3 trial
SLIDE 41 41
Most ICHs Should Be Care For At CSCs
IV TPA Delivery Tertiary Care (Telestroke, Transfers, Education, etc.) Comprehensive Stroke Centre Primary Stroke Centre Proposed Primary Stroke Centre
Calgary Zone
1,326,115
Calgary serves as the only comprehensive care centre in the south and the primary care centre for an area with over 1.3 million residents (2009)
SLIDE 42 Key Messages
- ICH 2nd most common stroke
- BP control to systolic ~140 mmHg quickly
- Correction of coagulopathy needed STAT
- Bleeding occurs very early which has
limited development of hemostatic tx.
- Surgery offered in moderate sized cerebral
- r large cerebellar ICH
- Minimally invasive surgery promising
SLIDE 43
Thank You for your attention